BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Knobler H, Malnick S. Hepatitis C and insulin action: An intimate relationship. World J Hepatol 2016; 8(2): 131-138 [PMID: 26807209 DOI: 10.4254/wjh.v8.i2.131]
URL: https://www.wjgnet.com/1948-5182/full/v8/i2/131.htm
Number Citing Articles
1
Ahmed Farouk Alaarag, Ahmed Mohamed Hamam, Osama Ahmed Amin. The Safety of The Directly Acting Antiviral Treatment For Hepatitis C Virus According To The Egyptian National Program Protocol In Patients With Midrange Ejection FractionGlobal Heart 2021; 16(1) doi: 10.5334/gh.906
2
Rowan Hillson. Viruses and diabetesPractical Diabetes 2016; 33(6): 190 doi: 10.1002/pdi.2034
3
Kazuyuki Suzuki, Ryujin Endo, Akinobu Kato. Liver Cirrhosis - Update and Current Challenges2017;  doi: 10.5772/intechopen.68828
4
Ines Bilić-Ćurčić, Hrvoje Roguljić, Marul Ivandić, Aleksandar Včev, Robert Smolić, Martina Smolić. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70721
5
Silvia Fabiani, Poupak Fallahi, Silvia Martina Ferrari, Mario Miccoli, Alessandro Antonelli. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literatureReviews in Endocrine and Metabolic Disorders 2018; 19(4): 405 doi: 10.1007/s11154-017-9440-1
6
Francesco Paolo Russo, Alberto Zanetto, Martina Gambato, Ilaria Bortoluzzi, Ramona Al Zoairy, Enrica Franceschet, Federica De Marchi, Luca Marzi, Erica Nicola Lynch, Annarosa Floreani, Fabio Farinati, Benedikt Schaefer, Patrizia Burra, Heinz Zoller, Andrea Mega. Hepatitis C virus eradication with direct‐acting antiviral improves insulin resistanceJournal of Viral Hepatitis 2020; 27(2): 188 doi: 10.1111/jvh.13215
7
Mohammed Elhendawy, Lobna Abo-Ali, Sherief Abd-Elsalam, Maha M. Hagras, Ibrahim Kabbash, Loai Mansour, Sherief Atia, Gamal Esmat, Abdel-Raouf Abo-ElAzm, Ferial El-Kalla, Abdelrahman Kobtan. HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infectionEnvironmental Science and Pollution Research 2020; 27(27): 33659 doi: 10.1007/s11356-020-09591-6
8
Sameh Mohamed Elgouhary, Khaled Elgonemy Said-Ahmed, Mahmoud Ali Mowafy. Anatomical and Functional Retinal Complications of Combined Sofosbuvir and Ribavirin Therapy in Patients With Chronic Hepatitis C VirusOphthalmic Surgery, Lasers and Imaging Retina 2019; 50(1): 39 doi: 10.3928/23258160-20181212-06
9
Raoni Freitas Carvalho, Ajax Mercês Atta, Isabela Silva de Oliveira, Taciana Pereira Sant’Ana Santos, João Pedro A. Santos, Maria Isabel Schinoni, Maria Luiza Brito de Sousa-Atta. Adiponectin levels and insulin resistance among patients with chronic hepatitis CActa Tropica 2018; 178: 258 doi: 10.1016/j.actatropica.2017.12.004
10
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver DiseasesJournal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
11
Livia Melo Villar, Gabriela Cardoso Caldas, Leticia de Paula Scalioni, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Vanessa Alves Marques, Cristiane Alves Villela-Nogueira, Lia Laura Lewis-Ximenez, Elisabeth Lampe. High prevalence of insulin resistance among Brazilian chronic hepatitis C patientsArchives of Endocrinology and Metabolism 2017; 61(6): 628 doi: 10.1590/2359-3997000000315
12
Christiana Graf, Tania Welzel, Dimitra Bogdanou, Johannes Vermehren, Anita Beckel, Jörg Bojunga, Mireen Friedrich-Rust, Julia Dietz, Alica Kubesch, Antonia Mondorf, Sarah Fischer, Thomas Lutz, Philipp Stoffers, Eva Herrmann, Thierry Poynard, Stefan Zeuzem, Georg Dultz, Ulrike Mihm. Hepatitis C Clearance by Direct-Acting Antivirals Impacts Glucose and Lipid HomeostasisJournal of Clinical Medicine 2020; 9(9): 2702 doi: 10.3390/jcm9092702
13
Felix M. Wensveen, Marko Šestan, Tamara Turk Wensveen, Bojan Polić. ‘Beauty and the beast’ in infection: How immune–endocrine interactions regulate systemic metabolism in the context of infectionEuropean Journal of Immunology 2019; 49(7): 982 doi: 10.1002/eji.201847895
14
Irene Cacciola, Giuseppina Russo, Roberto Filomia, Concetta Pitrone, Gaia Caccamo, Annalisa Giandalia, Angela Alibrandi, Maria Stella Franzè, Serena Porcari, Sergio Maimone, Carlo Saitta, Giovanni Squadrito, Giovanni Raimondo. Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosisLiver International 2021; 41(9): 2059 doi: 10.1111/liv.14905
15
P. Pavone, T. Tieghi, G. d'Ettorre, M. Lichtner, R. Marocco, I. Mezzaroma, G. Passavanti, P. Vittozzi, C. Mastroianni, V. Vullo. HCV and diabetes: towards a ‘Sustained’ glycaemic improvement after treatment with DAAs? – Authors' replyClinical Microbiology and Infection 2017; 23(5): 344 doi: 10.1016/j.cmi.2016.12.004
16
Alicia Oca�a‑Mondrag�n, Jos� Mata‑Mar�n, Mario Uriarte‑L�pez, Carolina Bekker‑M�ndez, Enrique Alcal�‑Mart�nez, Rosa Ribas‑Aparicio, Luis Uribe‑Nogu�z, Dulce Rodr�guez‑Galindo, Mar�a Mart�nez‑Rodr�guez. Effect of branched‑chain amino acid supplementation on insulin resistance and quality of life in chronic hepatitis C patientsBiomedical Reports 2017;  doi: 10.3892/br.2017.1012
17
C. Fabrizio, A. Procopio, L. Scudeller, R. Dell’Acqua, G. Bruno, E. Milano, M. Milella, A. Saracino, G. Angarano. HCV and diabetes: towards a ‘sustained’ glycaemic improvement after treatment with DAAs?Clinical Microbiology and Infection 2017; 23(5): 342 doi: 10.1016/j.cmi.2016.09.021
18
Clarissa Cordeiro Alves Arrelias, Fernando Belissimo Rodrigues, Maria Teresa da Costa Gonçalves Torquato, Carla Regina de Souza Teixeira, Flávia Fernanda Luchetti Rodrigues, Maria Lucia Zanetti. Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitusRevista Latino-Americana de Enfermagem 2018; 26(0) doi: 10.1590/1518-8345.2774.3085
19
Hassan Yousef Zied, Nashwa Mohamed Abo Alnasr, Amal Said El-Bendary, Sherief Abd-Elsalam, Rasha Youssef Hagag. Effect of treatment with direct antiviral agents (DAAs) on glycemic control in patients with type 2 diabetes mellitus & hepatitis C virus genotype 4Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(4): 679 doi: 10.1016/j.dsx.2020.05.024